Illumina Body Map 2 (GSE30611)
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_+_96493803 Show fit | 3.14 |
ENST00000518385.5
ENST00000302190.9 |
syndecan 2 |
|
chr5_-_173328407 Show fit | 2.90 |
ENST00000265087.9
|
stanniocalcin 2 |
|
chr1_-_56579555 Show fit | 2.78 |
ENST00000371250.4
|
phospholipid phosphatase 3 |
|
chr2_+_46297397 Show fit | 2.40 |
ENST00000263734.5
|
endothelial PAS domain protein 1 |
|
chr10_+_100347225 Show fit | 2.36 |
ENST00000370355.3
|
stearoyl-CoA desaturase |
|
chr3_+_61561561 Show fit | 2.21 |
ENST00000474889.6
|
protein tyrosine phosphatase receptor type G |
|
chr7_-_19117625 Show fit | 2.17 |
ENST00000242261.6
|
twist family bHLH transcription factor 1 |
|
chr15_+_40929338 Show fit | 2.12 |
ENST00000249749.7
|
delta like canonical Notch ligand 4 |
|
chr1_+_162632454 Show fit | 2.02 |
ENST00000367921.8
ENST00000367922.7 |
discoidin domain receptor tyrosine kinase 2 |
|
chr12_-_16608183 Show fit | 2.02 |
ENST00000354662.5
ENST00000538051.5 |
LIM domain only 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 3.1 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 2.9 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 2.8 | GO:0008354 | germ cell migration(GO:0008354) |
0.2 | 2.4 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 2.4 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) |
0.7 | 2.2 | GO:2000793 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) cell proliferation involved in heart valve development(GO:2000793) |
0.3 | 2.2 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.4 | 2.1 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.2 | 2.0 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.1 | 2.0 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.4 | 2.0 | GO:0005595 | collagen type XII trimer(GO:0005595) |
0.0 | 2.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.3 | 1.6 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) TEAD-2-YAP complex(GO:0071149) |
0.0 | 1.5 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.2 | 1.3 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
0.0 | 1.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.8 | 0.8 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
0.1 | 0.8 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.0 | 0.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.7 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 3.2 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 3.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.5 | 2.8 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 2.7 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 2.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 2.4 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.1 | 2.1 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 2.0 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.1 | 2.0 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 6.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 4.8 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 4.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 2.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 2.2 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 2.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 1.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 1.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 1.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 1.5 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 2.6 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 2.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 2.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 2.2 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.0 | 1.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 1.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 1.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.7 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |